D.E. Shaw & Co’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.53B | Buy |
24,312,352
+13,063,148
| +116% | +$1.05B | 0.92% | 7 |
|
|
2025
Q4 | $1.07B | Buy |
11,249,204
+2,338,849
| +26% | +$229M | 0.59% | 13 |
|
|
2025
Q3 | $870M | Buy |
8,910,355
+2,155,204
| +32% | +$223M | 0.49% | 18 |
|
|
2025
Q2 | $726M | Buy |
6,755,151
+2,916,007
| +76% | +$295M | 0.51% | 19 |
|
|
2025
Q1 | $387M | Buy |
3,839,144
+3,075,641
| +403% | +$310M | 0.34% | 36 |
|
|
2024
Q4 | $68.2M | Sell |
763,503
-992,596
| -57% | -$87.4M | 0.05% | 451 |
|
|
2024
Q3 | $147M | Buy |
1,756,099
+937,465
| +115% | +$73.9M | 0.13% | 177 |
|
|
2024
Q2 | $63M | Sell |
818,634
-580,159
| -41% | -$42.5M | 0.06% | 380 |
|
|
2024
Q1 | $95.8M | Buy |
1,398,793
+879,341
| +169% | +$56.5M | 0.08% | 276 |
|
|
2023
Q4 | $30M | Sell |
519,452
-618,105
| -54% | -$33M | 0.03% | 693 |
|
|
2023
Q3 | $60.1M | Sell |
1,137,557
-28,268
| -2% | -$1.48M | 0.06% | 368 |
|
|
2023
Q2 | $63.1M | Buy |
1,165,825
+694,070
| +147% | +$36.3M | 0.06% | 359 |
|
|
2023
Q1 | $23.6M | Sell |
471,755
-355,371
| -43% | -$16.7M | 0.03% | 792 |
|
|
2022
Q4 | $38.3M | Sell |
827,126
-994,886
| -55% | -$43.1M | 0.04% | 546 |
|
|
2022
Q3 | $70.6M | Sell |
1,822,012
-854,832
| -32% | -$34.3M | 0.08% | 266 |
|
|
2022
Q2 | $99.8M | Buy |
2,676,844
+2,092,621
| +358% | +$85.2M | 0.12% | 187 |
|
|
2022
Q1 | $25.9M | Sell |
584,223
-872,392
| -60% | -$37.8M | 0.02% | 862 |
|
|
2021
Q4 | $61.9M | Buy |
1,456,615
+1,138,662
| +358% | +$47.8M | 0.05% | 456 |
|
|
2021
Q3 | $13.8M | Buy |
317,953
+217,113
| +215% | +$9.61M | 0.01% | 1274 |
|
|
2021
Q2 | $4.31M | Sell |
100,840
-1,640,904
| -94% | -$69M | ﹤0.01% | 2179 |
|
|
2021
Q1 | $67.3M | Sell |
1,741,744
-8,205,986
| -82% | -$311M | 0.07% | 364 |
|
|
2020
Q4 | $358M | Buy |
9,947,730
+9,342,156
| +1,543% | +$337M | 0.32% | 45 |
|
|
2020
Q3 | $23.1M | Sell |
605,574
-2,543,728
| -81% | -$98M | 0.02% | 753 |
|
|
2020
Q2 | $111M | Sell |
3,149,302
-196,944
| -6% | -$7.09M | 0.13% | 148 |
|
|
2020
Q1 | $109M | Buy |
3,346,246
+3,101,659
| +1,268% | +$121M | 0.17% | 124 |
|
|
2019
Q4 | $11.1M | Buy |
244,587
+127,665
| +109% | +$5.34M | 0.01% | 1133 |
|
|
2019
Q3 | $4.76M | Sell |
116,922
-305,601
| -72% | -$12.9M | 0.01% | 1686 |
|
|
2019
Q2 | $18.2M | Sell |
422,523
-227,153
| -35% | -$8.74M | 0.02% | 801 |
|
|
2019
Q1 | $24.9M | Buy |
649,676
+524,028
| +417% | +$20M | 0.03% | 628 |
|
|
2018
Q4 | $4.44M | Buy |
125,648
+43,218
| +52% | +$1.57M | 0.01% | 1587 |
|
|
2018
Q3 | $3.17M | Sell |
82,430
-822,564
| -91% | -$28.7M | ﹤0.01% | 1880 |
|
|
2018
Q2 | $29.6M | Sell |
904,994
-3,492,231
| -79% | -$105M | 0.04% | 541 |
|
|
2018
Q1 | $120M | Sell |
4,397,225
-1,071,968
| -20% | -$29.1M | 0.16% | 145 |
|
|
2017
Q4 | $136M | Buy |
5,469,193
+4,828,654
| +754% | +$133M | 0.19% | 113 |
|
|
2017
Q3 | $18.7M | Sell |
640,539
-280,076
| -30% | -$7.73M | 0.03% | 642 |
|
|
2017
Q2 | $25.5M | Sell |
920,615
-88,662
| -9% | -$2.35M | 0.04% | 498 |
|
|
2017
Q1 | $25.1M | Sell |
1,009,277
-1,498,460
| -60% | -$36.4M | 0.04% | 486 |
|
|
2016
Q4 | $54.2M | Buy |
2,507,737
+1,801,037
| +255% | +$39.3M | 0.09% | 262 |
|
|
2016
Q3 | $16.8M | Sell |
706,700
-617,951
| -47% | -$14.7M | 0.03% | 652 |
|
|
2016
Q2 | $31M | Sell |
1,324,651
-947,230
| -42% | -$20.5M | 0.06% | 401 |
|
|
2016
Q1 | $42.7M | Sell |
2,271,881
-639,652
| -22% | -$11.2M | 0.08% | 305 |
|
|
2015
Q4 | $53.7M | Sell |
2,911,533
-2,739,965
| -48% | -$49.1M | 0.08% | 293 |
|
|
2015
Q3 | $92.7M | Buy |
5,651,498
+1,323,536
| +31% | +$22.6M | 0.14% | 172 |
|
|
2015
Q2 | $76.6M | Sell |
4,327,962
-1,254,364
| -22% | -$22.4M | 0.11% | 211 |
|
|
2015
Q1 | $99.1M | Sell |
5,582,326
-2,370,829
| -30% | -$37.5M | 0.15% | 149 |
|
|
2014
Q4 | $105M | Buy |
7,953,155
+3,072,571
| +63% | +$39.3M | 0.14% | 165 |
|
|
2014
Q3 | $57.6M | Buy |
4,880,584
+1,137,962
| +30% | +$14.3M | 0.07% | 304 |
|
|
2014
Q2 | $47.8M | Buy |
3,742,622
+310,174
| +9% | +$4.03M | 0.07% | 342 |
|
|
2014
Q1 | $46.4M | Sell |
3,432,448
-2,470,439
| -42% | -$32.4M | 0.07% | 326 |
|
|
2013
Q4 | $71M | Sell |
5,902,887
-9,505,600
| -62% | -$112M | 0.1% | 209 |
|
|
2013
Q3 | $181M | Buy |
15,408,487
+4,078,945
| +36% | +$44.1M | 0.29% | 49 |
|
|
2013
Q2 | $105M | Buy |
+11,329,542
| New | +$96.1M | 0.2% | 94 |
|
Other funds holding BSX
VCM
VPM
D.E. Shaw & Co's BSX Position: Q1 2026 in Review
D.E. Shaw & Co increased its Boston Scientific (BSX) stake by 116% in Q1 2026, buying an estimated $1.05B and bringing the position to 24,312,352 shares worth $1.53B. The position accounts for 0.92% of the portfolio, ranked #7.
D.E. Shaw & Co first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- D.E. Shaw & Co held 24,312,352 shares of Boston Scientific worth $1.53B as of Q1 2026.
- D.E. Shaw & Co bought 13,063,148 Boston Scientific shares in Q1 2026, an estimated $1.05B.
- Boston Scientific made up 0.92% of D.E. Shaw & Co's portfolio in Q1 2026, its #7 holding.
- D.E. Shaw & Co first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.